Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes

Journal of the American College of Cardiology

Volumn 56, Issue 3, 2010, Pages 225-233

  Rijzewijk, Luuk J ^a   Jonker, Jacqueline T ^c   Van Der Meer, Rutger W ^c   Lubberink, Mark ^b   De Jong, Hugo W ^b,d   Romijn, Johannes A ^c   Bax, Jeroen J ^c   De Roos, Albert ^c   Heine, Robert J ^a,e   Twisk, Jos W ^b   Windhorst, Albert D ^b   Lammertsma, Adriaan A ^b   Smit, Johannes W A ^c   Diamant, Michaela ^a   Lamb, Hildo J ^c  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ELI LILLY AND COMPANY   (United States)

Author keywords

31P MR; 18F 2 fluoro 2 deoxy d glucose; 18F FDG; CAD; cardiovascular disease; coronary artery disease; CVD; left ventricular; LV; M I; MBF; MFAE; MMRglu; myocardial blood flow; myocardial fatty acid esterification; myocardial metabolic rate of glucose uptake; PCr ATP; phosphocreatine adenosine triphosphate; phosphorus 31 magnetic resonance; T2DM; type 2 diabetes mellitus; whole body insulin sensitivity

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; FATTY ACID; GLUCOSE; INSULIN; TRIACYLGLYCEROL; PHOSPHATE;

ADULT; ARTICLE; FATTY ACID METABOLISM; FATTY LIVER; GLUCOSE TRANSPORT; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE METABOLISM; HIGH ENERGY PHOSPHATE; HUMAN; INSULIN SENSITIVITY; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; CHEMISTRY; HEART; HEART MUSCLE; INSULIN RESISTANCE; LIVER; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY;

DIABETES MELLITUS, TYPE 2; GLUCOSE; HEART; HUMANS; INSULIN RESISTANCE; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; MYOCARDIUM; PHOSPHATES; POSITRON-EMISSION TOMOGRAPHY; TRIGLYCERIDES; VENTRICULAR FUNCTION, LEFT;

EID: 77955060310     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.02.049     Document Type: Article

References (37)

1. W.P. James The epidemiology of obesity: the size of the problem J Intern Med 263 2008 336 352
2. M.J. Garcia, P.M. McNamara, T. Gordon, and W.B. Kannel Morbidity and mortality in diabetics in the Framingham population Sixteen year follow-up study Diabetes 23 1974 105 111
3. S.M. Grundy, B. Howard, S. Smith Jr., R. Eckel, R. Redberg, and R.O. Bonow Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association Circulation 105 2002 2231 2239
4. S. Boudina, and E.D. Abel Diabetic cardiomyopathy revisited Circulation 115 2007 3213 3223
5. H. Ashrafian, M.P. Frenneaux, and L.H. Opie Metabolic mechanisms in heart failure Circulation 116 2007 434 448
6. G. Targher, L. Bertolini, and R. Padovani Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients Diabetes Care 30 2007 1212 1218 (Pubitemid 46684650)
7. A. Kotronen, and H. Yki-Jarvinen Fatty liver: a novel component of the metabolic syndrome Arterioscler Thromb Vasc Biol 28 2008 27 38
8. N. Stefan, K. Kantartzis, and J. Machann Identification and characterization of metabolically benign obesity in humans Arch Intern Med 168 2008 1609 1616
9. R.K. Schindhelm, M. Diamant, and S.J. Bakker Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus Eur J Clin Invest 35 2005 369 374
10. G. Targher, L. Bertolini, R. Padovani, L. Zenari, G. Zoppini, and G. Falezza Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation Diabetes Care 27 2004 2498 2500
11. G. Perseghin, G. Lattuada, and C.F. De Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver Hepatology 47 2008 51 58
12. R. Lautamaki, R. Borra, and P. Iozzo Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes Am J Physiol Endocrinol Metab 291 2006 E282 E290
13. R.W. van der Meer, L.J. Rijzewijk, and H.W. de Jong Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus Circulation 119 2009 2069 2077
14. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance Am J Physiol 237 1979 E214 E223
15. P. Herrero, L.R. Peterson, and J.B. McGill Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus J Am Coll Cardiol 47 2006 598 604
16. P. Knaapen, R. Boellaard, and M.J. Gotte Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy J Nucl Med 45 2004 1299 1304
17. F. Hermansen, S.D. Rosen, and F. Fath-Ordoubadi Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols Eur J Nucl Med 25 1998 751 759
18. P. Knaapen, L.M. van Campen, and C.C. de Cock Effects of cardiac resynchronization therapy on myocardial perfusion reserve Circulation 110 2004 646 651
19. H.W. de Jong, L.J. Rijzewijk, and M. Lubberink Kinetic models for analysing myocardial [(11)C]palmitate data Eur J Nucl Med Mol Imaging 36 2009 966 978
20. C.S. Patlak, R.G. Blasberg, and J.D. Fenstermacher Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data J Cereb Blood Flow Metab 3 1983 1 7
21. R.W. van der Meer, S. Hammer, and J.W. Smit Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects Diabetes 56 2007 2849 2853
22. B.P. Paelinck, A. de Roos, and J.J. Bax Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement J Am Coll Cardiol 45 2005 1109 1116
23. M. Diamant, H.J. Lamb, and M.A. van de Ree The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes J Clin Endocrinol Metab 90 2005 1495 1501
24. L.S. Szczepaniak, P. Nurenberg, and D. Leonard Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population Am J Physiol Endocrinol Metab 288 2005 E462 E468
25. M. Lazo, and J.M. Clark The epidemiology of nonalcoholic fatty liver disease: a global perspective Semin Liver Dis 28 2008 339 350
26. H.J. Lamb, J. Doornbos, and J.A. den Hollander Reproducibility of human cardiac 31P-NMR spectroscopy NMR Biomed 9 1996 217 227
27. L.J. Rijzewijk, R.W. van der Meer, and J.W. Smit Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus J Am Coll Cardiol 52 2008 1793 1799
28. J. van de Kerkhof, C.G. Schalkwijk, and C.J. Konings Nepsilon- (carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients Nephrol Dial Transplant 19 2004 910 916
29. D.M. Ouwens, M. Diamant, and M. Fodor Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification Diabetologia 50 2007 1938 1948
30. S.L. Coort, A. Bonen, G. van der Vusse, J.F. Glatz, and J.J. Luiken Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: role of sarcolemmal substrate transporters Mol Cell Biochem 299 2007 5 18
31. P. Chareonthaitawee, P.A. Kaufmann, O. Rimoldi, and P.G. Camici Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans Cardiovasc Res 50 2001 151 161
32. R. Lautamaki, K.E. Airaksinen, and M. Seppanen Insulin improves myocardial blood flow in patients with type 2 diabetes and coronary artery disease Diabetes 55 2006 511 516 (Pubitemid 43343283)
33. M. Diamant, H.J. Lamb, and Y. Groeneveld Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus J Am Coll Cardiol 42 2003 328 335
34. M. Scheuermann-Freestone, P.L. Madsen, and D. Manners Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes Circulation 107 2003 3040 3046
35. G. Perseghin, G. Ntali, and F. De Cobelli Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance Diabetes Care 30 2007 1520 1526
36. I.F. Kodde, S.J. van der Stok, R.T. Smolenski, and J.W. de Jong Metabolic and genetic regulation of cardiac energy substrate preference Comp Biochem Physiol A Mol Integr Physiol 146 2007 26 39
37. A.N. Carley, and D.L. Severson Fatty acid metabolism is enhanced in type 2 diabetic hearts Biochim Biophys Acta 1734 2005 112 126